Test Megamenü
Company We are YUMAB Career Partnering Services Antibody Libraries Antibody Discovery Antibody Engineering Antibody Humanization Technologies Newsroom Contact Company We are YUMAB Career Partnering Services
Company We are YUMAB Career Partnering Services Antibody Libraries Antibody Discovery Antibody Engineering Antibody Humanization Technologies Newsroom Contact Company We are YUMAB Career Partnering Services
THE NEEDA number of therapeutic options have been explored over the course of the COVID-19 pandemic, yet there is still no effective treatment for hospitalized
THE NEEDPreventing apoptopic cell loss in IBD and insulin-dependent diabetes patientsInsulin-like growth factor binding-protein 3 (IGFBP3) binds to Transmembrane Receptor 219 (TMEM219) on intestinal stem cells
USA, San Diego
Spain, Barcelona
Sweden, Stockholm
Switzerland, Basel
Japan, Yokohama
Germany, Heidelberg
